The structural basis of hyper IgM deficiency - CD40L mutations.

X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency characterised by an inability to produce immunoglobulins of the IgG, IgA and IgE isotypes. It is caused by mutations of CD40 ligand (CD40L, CD154), expressed on T-lymphocytes. The interaction of CD40L on T-cells and its receptor CD40 on B-cells is essential for lymphocyte signalling leading to immunoglobulin class switching and B-cell maturation. To understand the structural basis for XHIGM, we utilised bioinformatics methods to analyse all the known CD40L missense mutations at both the sequence and structural level. Our results demonstrate that the 35 different missense mutations have diverse effects on CD40L structure and function, affecting structural disorder and aggregation tendencies, stability maintaining contacts and electrostatic properties. Several mutations also affect residues essential in receptor binding and trimerisation. Experimental study of effects of mutations is laborious and time-consuming and at the structural level often almost impossible. By contrast, precise and useful information about effects of mutations on protein structure and function can readily be obtained by theoretical methods. In this study, all the XHIGM causing missense mutations could be explained in terms of CD40L structure and function. Thus, the molecular basis of the syndrome could be elucidated.

[1]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[2]  M. Vihinen,et al.  Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain , 2000, Journal of Molecular Medicine.

[3]  Tal Pupko,et al.  Structural Genomics , 2005 .

[4]  Jimin Pei,et al.  AL2CO: calculation of positional conservation in a protein sequence alignment , 2001, Bioinform..

[5]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[6]  Romero,et al.  Sequence Data Analysis for Long Disordered Regions Prediction in the Calcineurin Family. , 1997, Genome informatics. Workshop on Genome Informatics.

[7]  M. Vihinen,et al.  Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease. , 2000, Biochemical and biophysical research communications.

[8]  T. Gibson,et al.  Protein disorder prediction: implications for structural proteomics. , 2003, Structure.

[9]  I. Berberich,et al.  Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. , 1994, Journal of immunology.

[10]  D. Chasman,et al.  Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. , 2001, Journal of molecular biology.

[11]  M. Zalis,et al.  Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms. , 1999, Journal of molecular biology.

[12]  J. Belmont,et al.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome , 1993, Science.

[13]  L. Notarangelo,et al.  Defective Expression of CD40 Ligand on T Cells Causes “X‐Linked Immunodeficiency with Hyper‐IgM (HIGM1)” , 1994, Immunological reviews.

[14]  M. Vihinen,et al.  BTKbase: the mutation database for X‐linked agammaglobulinemia , 2006, Human mutation.

[15]  Piero Fariselli,et al.  ConSeq: the identification of functionally and structurally important residues in protein sequences , 2004, Bioinform..

[16]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[17]  L Serrano,et al.  Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. , 1997, Biopolymers.

[18]  J. Thornton,et al.  Molecular basis of inherited diseases: a structural perspective. , 2003, Trends in genetics : TIG.

[19]  J. Sowadski,et al.  Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Fischer,et al.  Clinical spectrum of X-linked hyper-IgM syndrome. , 1997, The Journal of pediatrics.

[21]  J. Banchereau,et al.  Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10 , 1993, The Journal of experimental medicine.

[22]  Modesto Orozco,et al.  PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..

[23]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[24]  G. Bishop,et al.  CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. , 1996, Journal of immunology.

[25]  Bairong Shen,et al.  Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. , 2004, Protein engineering, design & selection : PEDS.

[26]  Miki Nakagawa,et al.  Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[27]  V. Kindler,et al.  Interleukin‐2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross‐linking , 1995, European journal of immunology.

[28]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[29]  E. Clark,et al.  Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. , 1990, Journal of immunology.

[30]  R. Coffman,et al.  Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.

[31]  Bernard F. Buxton,et al.  The DISOPRED server for the prediction of protein disorder , 2004, Bioinform..

[32]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Bairong Shen,et al.  RankViaContact: ranking and visualization of amino acid contacts , 2003, Bioinform..

[34]  Teri E. Klein,et al.  The functional importance of disease-associated mutation , 2002, BMC Bioinformatics.

[35]  M. Vihinen,et al.  Structural Basis of Bloom Syndrome (BS) Causing Mutations in the BLM Helicase Domain , 2000, Molecular medicine.

[36]  M. Vihinen,et al.  Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. , 1994, Biochemical and biophysical research communications.

[37]  Marianne Rooman,et al.  PoPMuSiC, rationally designing point mutations in protein structures , 2002, Bioinform..

[38]  J. Tschopp,et al.  The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.

[39]  K. Strauch,et al.  Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody. , 2001, Structure.

[40]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[41]  J. H. Park,et al.  Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. , 1993, Blood.

[42]  J. Bajorath,et al.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.

[43]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[44]  J. Moult,et al.  SNPs, protein structure, and disease , 2001, Human mutation.

[45]  M Vihinen,et al.  CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. , 1996, Immunology today.

[46]  D. Richardson,et al.  Exploring steric constraints on protein mutations using MAGE/PROBE , 2000, Protein science : a publication of the Protein Society.

[47]  M C Peitsch,et al.  A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. , 1993, International immunology.

[48]  R. Geha,et al.  Activation of Tumor Necrosis Factor-α and Lymphotoxin-α via Anti-CD40 in Human B Cells , 1995 .

[49]  J. Woodgett,et al.  Cross‐linking CD40 on B cells preferentially induces stress‐activated protein kinases rather than mitogen‐activated protein kinases. , 1996, The EMBO journal.

[50]  I. Berberich,et al.  CD40 and its ligand in the regulation of humoral immunity. , 1994, Seminars in immunology.

[51]  J. Thompson,et al.  2 A crystal structure of an extracellular fragment of human CD40 ligand. , 1995, Structure.

[52]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[53]  Peng Yue,et al.  SNPs3D: Candidate gene and SNP selection for association studies , 2006, BMC Bioinformatics.

[54]  J. Bonifacino,et al.  Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. , 1991, The EMBO journal.

[55]  Y. Hsu,et al.  CD154 Variants Associated with Hyper-IgM Syndrome Can Form Oligomers and Trigger CD40-mediated Signals* , 1999, The Journal of Biological Chemistry.

[56]  M. Vihinen,et al.  Structural basis of ICF-causing mutations in the methyltransferase domain of DNMT3B. , 2002, Protein engineering.

[57]  I. Stamenkovic,et al.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Richardson,et al.  The penultimate rotamer library , 2000, Proteins.

[59]  Juswinder Singh,et al.  The role of polar interactions in the molecular recognition of CD40L with its receptor CD40 , 1998, Protein science : a publication of the Protein Society.

[60]  D Gilis,et al.  PoPMuSiC, an algorithm for predicting protein mutant stability changes: application to prion proteins. , 2000, Protein engineering.

[61]  E. Clark,et al.  Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. , 1996, Journal of immunology.

[62]  G. Bishop,et al.  Recruitment of CD40 and Tumor Necrosis Factor Receptor-associated Factors 2 and 3 to Membrane Microdomains during CD40 Signaling* , 2000, The Journal of Biological Chemistry.

[63]  M. Worm,et al.  Lymphotoxin‐α is an important autocrine factor for CD40+interleukin‐4‐mediated B‐cell activation in normal and atopic donors , 1998, Immunology.

[64]  Jaime Prilusky,et al.  Automated analysis of interatomic contacts in proteins , 1999, Bioinform..

[65]  E. Clark,et al.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[66]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[67]  Mauno Vihinen,et al.  Bioinformatic analysis of protein structure–function relationships: case study of leukocyte elastase (ELA2) missense mutations , 2006, Human mutation.

[68]  M. Gold,et al.  Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. , 1996, Journal of immunology.

[69]  Robert B. Russell,et al.  GlobPlot: exploring protein sequences for globularity and disorder , 2003, Nucleic Acids Res..

[70]  M. Miller,et al.  Understanding human disease mutations through the use of interspecific genetic variation. , 2001, Human molecular genetics.

[71]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[72]  M. Vihinen,et al.  Immunodeficiency mutation databases (IDbases) , 2006, Human mutation.

[73]  Obradovic,et al.  Predicting Protein Disorder for N-, C-, and Internal Regions. , 1999, Genome informatics. Workshop on Genome Informatics.

[74]  David Baltimore,et al.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Richardson,et al.  Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. , 1999, Journal of molecular biology.

[76]  W. Fanslow,et al.  Incorporation of an Isoleucine Zipper Motif Enhances the Biological Activity of Soluble CD40L (CD154)* , 1999, The Journal of Biological Chemistry.

[77]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[78]  C. Sander,et al.  The amino-acid mutational spectrum of human genetic disease , 2003, Genome Biology.